Shahrokh Shariat

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Disease Progression

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Karakiewicz Pierre I; Suardi Nazareno; Capitanio Umberto; Isbarn Hendrik; Jeldres Claudio; Perrotte Paul; Sun Maxine; Ficarra Vincenzo; Zigeuner Richard; Tostain Jacques; Mejean Arnaud; Cindolo Luca; Pantuck Allan J; Belldegrun Arie S; Zini Laurent; de la Taille Alexandre; Chautard Denis; Descotes Jean-Luc; Shariat Shahrokh F; Valeri Antoine; Mulders Peter F A; Lang Hervé; Lechevallier Eric; Patard Jean-Jacques
Conditional survival predictions after nephrectomy for renal cell carcinoma.
Shariat Shahrokh F; Karakiewicz Pierre I; Godoy Guilherme; Karam Jose A; Ashfaq Raheela; Fradet Yves; Isbarn Hendrik; Montorsi Francesco; Jeldres Claudio; Bastian Patrick J; Nielsen Matthew E; Müller Stefan C; Sagalowsky Arthur I; Lotan Yair
Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.
Roscigno Marco; Shariat Shahrokh F; Freschi Massimo; Margulis Vitaly; Karakiewizc Pierre; Suardi Nazareno; Remzi Mesut; Zigeuner Richard; Bolenz Christian; Kikuchi Eiji; Weizer Alon; Bensalah Karim; Sagalowsky Arthur; Koppie Theresa M; Raman Jay; Fernández Mario; Ströbel Philipp; Kabbani Wareef; Langner Cord; Wheat Jeffery; Guo Charles C; Kassouf Wassim; Haitel Andrea; Wood Christopher G; Montorsi Francesco
Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Shahrokh Shariat (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Karakiewicz Pierre I; Suardi Nazareno; Capitanio Umberto; Isbarn Hendrik; Jeldres Claudio; Perrotte Paul; Sun Maxine; Ficarra Vincenzo; Zigeuner Richard; Tostain Jacques; Mejean Arnaud; Cindolo Luca; Pantuck Allan J; Belldegrun Arie S; Zini Laurent; de la Taille Alexandre; Chautard Denis; Descotes Jean-Luc; Shariat Shahrokh F; Valeri Antoine; Mulders Peter F A; Lang Hervé; Lechevallier Eric; Patard Jean-Jacques
Conditional survival predictions after nephrectomy for renal cell carcinoma.
The Journal of urology 2009;182(6):2607-12.
2009: Shariat Shahrokh F; Karakiewicz Pierre I; Godoy Guilherme; Karam Jose A; Ashfaq Raheela; Fradet Yves; Isbarn Hendrik; Montorsi Francesco; Jeldres Claudio; Bastian Patrick J; Nielsen Matthew E; Müller Stefan C; Sagalowsky Arthur I; Lotan Yair
Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):7012-9.
2009: Roscigno Marco; Shariat Shahrokh F; Freschi Massimo; Margulis Vitaly; Karakiewizc Pierre; Suardi Nazareno; Remzi Mesut; Zigeuner Richard; Bolenz Christian; Kikuchi Eiji; Weizer Alon; Bensalah Karim; Sagalowsky Arthur; Koppie Theresa M; Raman Jay; Fernández Mario; Ströbel Philipp; Kabbani Wareef; Langner Cord; Wheat Jeffery; Guo Charles C; Kassouf Wassim; Haitel Andrea; Wood Christopher G; Montorsi Francesco
Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.
Urology 2009;74(5):1070-4.
2009: Shariat Shahrokh F; Milowsky Matthew; Droller Michael J
Bladder cancer in the elderly.
Urologic oncology 2009;27(6):653-67.
2009: Isbarn Hendrik; Jeldres Claudio; Shariat Shahrokh F; Liberman Daniel; Sun Maxine; Lughezzani Giovanni; Widmer Hugues; Arjane Philippe; Pharand Daniel; Fisch Margit; Graefen Markus; Montorsi Francesco; Perrotte Paul; Karakiewicz Pierre I
Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
The Journal of urology 2009;182(5):2177-81.
2009: Jeldres Claudio; Cardinal Héloïse; Duclos Alain; Shariat Shahrokh F; Suardi Nazareno; Capitanio Umberto; Hébert Marie-Josèe; Karakiewicz Pierre I
Prediction of delayed graft function after renal transplantation.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2009;3(5):377-82.
2009: Lughezzani Giovanni; Jeldres Claudio; Isbarn Hendrik; Perrotte Paul; Shariat Shahrokh F; Sun Maxine; Widmer Hugues; Arjane Philippe; Peloquin Francois; Pharand Daniel; Patard Jean-Jacques; Graefen Markus; Montorsi Francesco; Karakiewicz Pierre I
Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
The Journal of urology 2009;182(4):1287-93.
2009: Crépel Maxime; Isbarn Hendrik; Capitanio Umberto; Liberman Daniel; Jeldres Claudio; Sun Maxine; Shariat Shahrokh F; Widmer Hugues; Arjane Philippe; Graefen Markus; Montorsi Francesco; Patard Jean-Jacques; Perrotte Paul; Karakiewicz Pierre I
Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?
Urology 2009;74(4):842-5.
2009: Capitanio Umberto; Isbarn Hendrik; Shariat Shahrokh F; Jeldres Claudio; Zini Laurent; Saad Fred; Graefen Markus; Montorsi Francesco; Perrotte Paul; Karakiewicz Pierre I
Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist.
Urology 2009;74(4):858-64.
2009: Jeldres Claudio; Baillargeon-Gagne Sara; Liberman Daniel; Isbarn Hendrik; Capitanio Umberto; Shariat Shahrokh F; Sun Maxine; Lughezzani Giovanni; Perrotte Paul; Montorsi Francesco; Graefen Markus; Karakiewicz Pierre I
A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.
Urology 2009;74(4):837-41.
2009: Godoy Guilherme; Chade Daher C; Shariat Shahrokh F
Words of wisdom. Re: Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy. Polascik TJ, Mayes JM, Sun L, Madden JF, Moul JW, Mouraviev V.
European urology 2009;56(3):573-5.
2009: Nuss Geoffrey R; Morey Allen F; Jenkins Adam C; Pruitt Jeffrey H; Dugi Daniel D; Morse Brian; Shariat Shahrokh F
Radiographic predictors of need for angiographic embolization after traumatic renal injury.
The Journal of trauma 2009;67(3):578-82; discussion 582.
2009: Shariat Shahrokh F; Lotan Yair; Karakiewicz Pierre I; Ashfaq Raheela; Isbarn Hendrik; Fradet Yves; Bastian Patrick J; Nielsen Matthew E; Capitanio Umberto; Jeldres Claudio; Montorsi Francesco; Müller Stefan C; Karam Jose A; Heukamp Lukas C; Netto George; Lerner Seth P; Sagalowsky Arthur I; Cote Richard J
p53 predictive value for pT1-2 N0 disease at radical cystectomy.
The Journal of urology 2009;182(3):907-13.
2009: Hellenthal Nicholas J; Shariat Shahrokh F; Margulis Vitaly; Karakiewicz Pierre I; Roscigno Marco; Bolenz Christian; Remzi Mesut; Weizer Alon; Zigeuner Richard; Bensalah Karim; Ng Casey K; Raman Jay D; Kikuchi Eiji; Montorsi Francesco; Oya Mototsugu; Wood Christopher G; Fernandez Mario; Evans Christopher P; Koppie Theresa M
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
The Journal of urology 2009;182(3):900-6.
2009: Roscigno Marco; Shariat Shahrokh F; Margulis Vitaly; Karakiewicz Pierre; Remzi Mesut; Kikuchi Eiji; Zigeuner Richard; Weizer Alon; Sagalowsky Arthur; Bensalah Karim; Raman Jay D; Bolenz Christian; Kassou Wassim; Koppie Theresa M; Wood Christopher G; Wheat Jeffrey; Langner Cord; Ng Casey K; Capitanio Umberto; Bertini Roberto; Fernández Mario I; Mikami Shuji; Isida Masaru; Ströbel Philipp; Montorsi Francesco
The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?
European urology 2009;56(3):512-8.
2009: Capitanio Umberto; Perrotte Paul; Zini Laurent; Jeldres Claudio; Shariat Shahrokh F; Isbarn Hendrik; Arjane Philippe; Peloquin François; Pharand Daniel; Montorsi Francesco; Karakiewicz Pierre I
Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
BJU international 2009;104(6):795-9.
2009: Isbarn Hendrik; Jeldres Claudio; Capitanio Umberto; Zini Laurent; Shariat Shahrokh F; Lughezzani Giovanni; Sun Maxine; Ahyai Sascha A; Duclos Alain; Jolivet-Tremblay Martine; Lattouf Jean-Baptiste; Valiquette Luc; Perrotte Paul; Montorsi Francesco; Graefen Markus; Karakiewicz Pierre I
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy.
Journal of endourology / Endourological Society 2009;23(8):1347-52.
2009: Jeldres Claudio; Isbarn Hendrik; Capitanio Umberto; Zini Laurent; Bhojani Naeem; Shariat Shahrokh F; Cloutier Vincent; Lattouf Jean-Baptiste; Duclos Alain; Jolivet-Tremblay Martine; Valiquette Luc; Saad Fred; Graefen Markus; Montorsi Francesco; Perrotte Paul; Karakiewicz Pierre I
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
The Journal of urology 2009;182(2):626-32.
2009: Isbarn Hendrik; Karakiewicz Pierre I; Shariat Shahrokh F; Capitanio Umberto; Palapattu Ganesh S; Sagalowsky Arthur I; Lotan Yair; Schoenberg Mark P; Amiel Gilad E; Lerner Seth P; Sonpavde Guru
Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
The Journal of urology 2009;182(2):459-65; discussion 465.
2009: Capitanio Umberto; Jeldres Claudio; Perrotte Paul; Isbarn Hendrik; Crépel Maxime; Cloutier Vincent; Baillargeon-Gagne Sara; Shariat Shahrokh F; Duclos Alain; Arjane Philippe; Widmer Hugues; Saad Fred; Montorsi Francesco; Karakiewicz Pierre I
Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors.
Urology 2009;74(2):373-7.
2009: Isbarn Hendrik; Jeldres Claudio; Zini Laurent; Perrotte Paul; Baillargeon-Gagne Sara; Capitanio Umberto; Shariat Shahrokh F; Arjane Phillipe; Saad Fred; McCormack Michael; Valiquette Luc; Peloquin Francois; Duclos Alain; Montorsi Francesco; Graefen Markus; Karakiewicz Pierre I
A population based assessment of perioperative mortality after cystectomy for bladder cancer.
The Journal of urology 2009;182(1):70-7.
2009: Shariat Shahrokh F; Bolenz Christian; Godoy Guilherme; Fradet Yves; Ashfaq Raheela; Karakiewicz Pierre I; Isbarn Hendrik; Jeldres Claudio; Rigaud Jérôme; Sagalowsky Arthur I; Lotan Yair
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
The Journal of urology 2009;182(1):78-84; discussion 84.
2009: Capitanio Umberto; Perrotte Paul; Zini Laurent; Suardi Nazareno; Antebi Elie; Cloutier Vincent; Jeldres Claudio; Shariat Shahrokh F; Duclos Alain; Arjane Philippe; Saad Fred; Montorsi Francesco; Karakiewicz Pierre I
Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort.
Urology 2009;73(6):1323-7.
2009: Roscigno Marco; Shariat Shahrokh F; Margulis Vitaly; Karakiewicz Pierre; Remzi Mesut; Kikuchi Eiji; Langner Cord; Lotan Yair; Weizer Alon; Bensalah Karim; Raman Jay D; Bolenz Christian; Guo Charles C; Wood Christopher G; Zigeuner Richard; Wheat Jeffrey; Kabbani Wareef; Koppie Theresa M; Ng Casey K; Suardi Nazareno; Bertini Roberto; Fernández Mario I; Mikami Shuji; Isida Masaru; Michel Maurice Stephan; Montorsi Francesco
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
The Journal of urology 2009;181(6):2482-9.
2009: Svatek Robert S; Jeldres Claudio; Karakiewicz Pierre I; Suardi Nazareno; Walz Jochen; Roehrborn Claus G; Montorsi Francesco; Slawin Kevin M; Shariat Shahrokh F
Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence.
The Prostate 2009;69(8):886-94.
2009: Capitanio Umberto; Cloutier Vincent; Zini Laurent; Isbarn Hendrik; Jeldres Claudio; Shariat Shahrokh F; Perrotte Paul; Antebi Elie; Patard Jean-Jacques; Montorsi Francesco; Karakiewicz Pierre I
A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study.
BJU international 2009;103(11):1496-500.
2009: Lotan Yair; Capitanio Umberto; Shariat Shahrokh F; Hutterer Georg C; Karakiewicz Pierre I
Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.
BJU international 2009;103(10):1368-74.
2009: Capitanio Umberto; Suardi Nazareno; Shariat Shahrokh F; Lotan Yair; Palapattu Ganesh S; Bastian Patrick J; Gupta Amit; Vazina Amnon; Schoenberg Mark; Lerner Seth P; Sagalowsky Arthur I; Karakiewicz Pierre I
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer.
BJU international 2009;103(10):1359-62.
2009: Gupta Amit; Lotan Yair; Ashfaq Raheela; Roehrborn Claus G; Raj Ganesh V; Aragaki Corinne C; Montorsi Francesco; Shariat Shahrokh F
Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
European urology 2009;55(5):1124-33.
2009: Zini Laurent; Perrotte Paul; Capitanio Umberto; Jeldres Claudio; Shariat Shahrokh F; Antebi Elie; Saad Fred; Patard Jean-Jacques; Montorsi Francesco; Karakiewicz Pierre I
Radical versus partial nephrectomy: effect on overall and noncancer mortality.
Cancer 2009;115(7):1465-71.
2009: Zorn Kevin C; Capitanio Umberto; Jeldres Claudio; Arjane Philippe; Perrotte Paul; Shariat Shahrokh F; Lee David I; Shalhav Arieh L; Zagaja Gregory P; Shikanov Sergey A; Gofrit Ofer N; Thong Alan E; Albala David M; Sun Leon; Karakiewicz Pierre I
Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables.
International journal of radiation oncology, biology, physics 2009;73(5):1461-7.
2009: Margulis Vitaly; Shariat Shahrokh F; Matin Surena F; Kamat Ashish M; Zigeuner Richard; Kikuchi Eiji; Lotan Yair; Weizer Alon; Raman Jay D; Wood Christopher G;
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Cancer 2009;115(6):1224-33.
2009: Shariat Shahrokh F; Svatek Robert S
Editorial comment on: Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
European urology 2009;55(3):626-8.
2009: Zini Laurent; Cloutier Vincent; Isbarn Hendrik; Perrotte Paul; Capitanio Umberto; Jeldres Claudio; Shariat Shahrokh F; Saad Fred; Arjane Philippe; Duclos Alain; Lattouf Jean-Baptiste; Montorsi Francesco; Karakiewicz Pierre I
A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):1013-8.
2009: Kikuchi Eiji; Margulis Vitaly; Karakiewicz Pierre I; Roscigno Marco; Mikami Shuji; Lotan Yair; Remzi Mesut; Bolenz Christian; Langner Cord; Weizer Alon; Montorsi Francesco; Bensalah Karim; Koppie Theresa M; Fernández Mario I; Raman Jay D; Kassouf Wassim; Wood Christopher G; Suardi Nazareno; Oya Mototsugu; Shariat Shahrokh F
Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):612-8.
2009: Zini Laurent; Capitanio Umberto; Perrotte Paul; Jeldres Claudio; Shariat Shahrokh F; Arjane Philippe; Widmer Hugues; Montorsi Francesco; Patard Jean-Jacques; Karakiewicz Pierre I
Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.
Urology 2009;73(2):342-6.
2009: Bhojani Naeem; Salomon Laurent; Capitanio Umberto; Suardi Nazareno; Shariat Shahrokh F; Jeldres Claudio; Zini Laurent; Pharand Daniel; Péloquin François; Arjane Philippe; Abbou Claude C; De La Taille Alexandre; Montorsi Francesco; Karakiewicz Pierre I
External validation of the updated partin tables in a cohort of French and Italian men.
International journal of radiation oncology, biology, physics 2009;73(2):347-52.
2009: Bolenz Christian; Shariat Shahrokh F; Fernández Mario I; Margulis Vitaly; Lotan Yair; Karakiewicz Pierre; Remzi Mesut; Kikuchi Eiji; Zigeuner Richard; Weizer Alon; Montorsi Francesco; Bensalah Karim; Wood Christopher G; Roscigno Marco; Langner Cord; Koppie Theresa M; Raman Jay D; Mikami Shuji; Michel Maurice Stephan; Ströbel Philipp
Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density.
BJU international 2009;103(3):302-6.
2009: Remzi Mesut; Haitel Andrea; Margulis Vitaly; Karakiewicz Pierre; Montorsi Francesco; Kikuchi Eiji; Zigeuner Richard; Weizer Alon; Bolenz Christian; Bensalah Karim; Suardi Nazareno; Raman Jay D; Lotan Yair; Waldert Matthias; Ng Casey K; Fernández Mario; Koppie Theresa M; Ströbel Philipp; Kabbani Wareef; Murai Masaru; Langner Cord; Roscigno Marco; Wheat Jeffrey; Guo Charles C; Wood Christopher G; Shariat Shahrokh F
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
BJU international 2009;103(3):307-11.
2009: Shariat Shahrokh F; Capitanio Umberto; Jeldres Claudio; Karakiewicz Pierre I
Can nomograms be superior to other prediction tools?
BJU international 2009;103(4):492-5; discussion 495-7.
2009: Bhojani N; Ahyai S; Graefen M; Capitanio U; Suardi N; Shariat S F; Jeldres C; Erbersdobler A; Schlomm T; Haese A; Steuber T; Heinzer H; Montorsi F; Huland H; Karakiewicz P I
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(2):123-8.
2009: Margulis Vitaly; Lotan Yair; Karakiewicz Pierre I; Fradet Yves; Ashfaq Raheela; Capitanio Umberto; Montorsi Francesco; Bastian Patrick J; Nielsen Matthew E; Müller Stefan C; Rigaud Jérôme; Heukamp Lukas C; Netto George; Lerner Seth P; Sagalowsky Arthur I; Shariat Shahrokh F
Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer.
Journal of the National Cancer Institute 2009;101(2):114-9.
2009: Capitanio Umberto; Perrotte Paul; Hutterer Georg C; Suardi Nazareno; Jeldres Claudio; Shariat Shahrokh F; Duclos Alain; Arjane Philippe; Montorsi Francesco; Karakiewicz Pierre I
Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men.
International journal of urology : official journal of the Japanese Urological Association 2009;16(1):91-5.
2009: Fernández Mario I; Shariat Shahrokh F; Margulis Vitaly; Bolenz Christian; Montorsi Francesco; Suardi Nazareno; Remzi Mesut; Wood Christopher G; Roscigno Marco; Kikuchi Eiji; Oya Mototsugu; Zigeuner Richard; Langner Cord; Weizer Alon; Lotan Yair; Koppie Theresa M; Raman Jay D; Karakiewizc Pierre; Bensalah Karim; Schultz Marcela; Bernier Pablo
Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.
Urology 2009;73(1):142-6.
2009: Shariat Shahrokh F; Zimmern Philippe E; Hilton Kathleen; Gruchalla Rebecca S
Prospective questionnaire-based evaluation of the prevalence of urinary incontinence in women with chronic cough.
Urologia internationalis 2009;83(2):181-6.
2008: Shariat Shahrokh F; Scardino Peter T; Lilja Hans
Screening for prostate cancer: an update.
The Canadian journal of urology 2008;15(6):4363-74.
2008: Shariat Shahrokh F; Karakiewicz Pierre I; Roehrborn Claus G; Kattan Michael W
An updated catalog of prostate cancer predictive tools.
Cancer 2008;113(11):3075-99.
2008: Capitanio Umberto; Ahyai Sasha; Graefen Markus; Jeldres Claudio; Shariat Shahrokh F; Erbersdobler Andreas; Schlomm Thorsten; Haese Alexander; Steuber Thomas; Heinzer Hans; Perrotte Paul; Péloquin François; Pharand Daniel; Arjane Philippe; Huland Hartwig; Karakiewicz Pierre I
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
Urology 2008;72(6):1208-11; discussion 1212-3.
2008: Karam Jose A; Shariat Shahrokh F; Hsieh Jer-Tsong; Knowles Margaret A
Genomics: a preview of genomic medicine.
BJU international 2008;102(9 Pt B):1221-7.
2008: Gupta Amit; Karakiewicz Pierre I; Roehrborn Claus G; Lotan Yair; Zlotta Alexandre R; Shariat Shahrokh F
Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7385-90.
2008: Capitanio Umberto; Zini Laurent; Perrotte Paul; Shariat Shahrokh F; Jeldres Claudio; Arjane Philippe; Pharand Daniel; Widmer Hugues; Péloquin François; Montorsi Francesco; Patard Jean-Jacques; Karakiewicz Pierre I
Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
Urology 2008;72(5):1090-5.
2008: Shariat Shahrokh F; Bolenz Christian; Karakiewicz Pierre I
Words of wisdom. Re: Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Escudier B, Pluzanska A, Koralewski P, et al., for the AVOREN Trial investigators.
European urology 2008;54(4):948-9.
2008: Shariat Shahrokh F; Roehrborn Claus G; Lamb Dolores J; Slawin Kevin M
Notice of duplicate publication: "Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis" (arch intern med. 2008;168[2]:235-236).
Archives of internal medicine 2008;168(18):2046-7.
2008: Capitanio Umberto; Briganti Alberto; Shariat Shahrokh F; Karakiewicz Pierre I
The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspective.
European urology 2008;54(4):717-9.
2008: Shariat Shahrokh F
Editorial comment on: Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
European urology 2008;54(4):803-4.
2008: Capitanio Umberto; Jeldres Claudio; Shariat Shahrokh F; Karakiewicz Pierre
Clinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second best.
European urology 2008;54(4):958-9.
2008: Karam Jose A; Margulis Vitaly; Montorsi Francesco; Karakiewicz Pierre I; Lotan Yair; Kikuchi Eiji; Weizer Alon; Zigeuner Richard; Bolenz Christian; Shariat Shahrokh F
Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy--results from a multicenter study.
European urology 2008;54(4):961-3.
2008: Svatek Robert; Shariat Shahrokh F
Re: lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
European urology 2008;54(3):690-1.
2008: Karakiewicz Pierre I; Bhojani Naeem; Capitanio Umberto; Reuther Alwyn M; Suardi Nazareno; Jeldres Claudio; Pharand Daniel; Péloquin François; Perrotte Paul; Shariat Shahrokh F; Klein Eric A
External validation of the updated Partin tables in a cohort of North American men.
The Journal of urology 2008;180(3):898-902; discussion 902-3.
2008: Shariat Shahrokh F; Jenkins Adam; Roehrborn Claus G; Karam Jose A; Stage Key H; Karakiewicz Pierre I
Features and outcomes of patients with grade IV renal injury.
BJU international 2008;102(6):728-33; discussion 733.
2008: Bhojani Naeem; Perrotte Paul; Hutterer Georg; Suardi Nazareno; Jeldres Claudio; Shariat Shahrokh F; Capitanio Umberto; Arjane Philippe; Widmer Hugues; Benard Francois; Peloquin Francois; Montorsi Francesco; Karakiewicz Pierre
Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening.
The journal of sexual medicine 2008;5(9):2141-51.
2008: Jeldres Claudio; Suardi Nazareno; Capitanio Umberto; Montorsi Francesco; Shariat Shahrokh F; Perrotte Paul; Peloquin Francois; Pharand Daniel; Graefen Markus; Karakiewicz Pierre I
High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer.
BJU international 2008;102(4):463-7.
2008: Gallina Andrea; Suardi Nazareno; Montorsi Francesco; Capitanio Umberto; Jeldres Claudio; Saad Fred; Graefen Markus; Shariat Shahrokh F; Widmer Hugues; Arjane Philippe; Péloquin François; Perrotte Paul; Karakiewicz Pierre I
Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.
International journal of cancer. Journal international du cancer 2008;123(3):647-52.
2008: Shariat Shahrokh F; Karakiewicz Pierre I; Suardi Nazareno; Kattan Michael W
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4400-7.
2008: Walz Jochen; Suardi Nazareno; Shariat Shahrokh F; Jeldres Claudio; Perrotte Paul; Graefen Markus; Widmer Hughes; Arjane Philippe; Valiquette Luc; Hutterer Georg; Saad Fred; Karakiewicz Pierre I
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
BJU international 2008;102(1):33-8.
2008: Shariat Shahrokh F; Margulis Vitaly; Karakiewicz Pierre I
Rebuttal from authors re: James W.F. Catto. More nomograms or better evidence of efficacy: what do we need in urologic oncology? Eur Urol 2008;54:11-12.
European urology 2008;54(1):13-5.
2008: Margulis Vitaly; Lotan Yair; Montorsi Francesco; Shariat Shahrokh F
Predicting survival after radical cystectomy for bladder cancer.
BJU international 2008;102(1):15-22.
2008: Shariat Shahrokh F; Karakiewicz Pierre I
Perspectives on prostate cancer biomarkers.
European urology 2008;54(1):8-10.
2008: Shariat Shahrokh F; Margulis Vitaly; Lotan Yair; Montorsi Francesco; Karakiewicz Pierre I
Nomograms for bladder cancer.
European urology 2008;54(1):41-53.
2008: Jeldres Claudio; Suardi Nazareno; Saad Fred; Montorsi Francesco; Shariat Shahrokh F; Perrotte Paul; Bhojani Naeem; Walz Jochen; Hutterer Georg C; Graefen Markus; Valiquette Luc; Karakiewicz Pierre I
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.
European urology 2008;54(1):97-105.
2008: Jeldres Claudio; Suardi Nazareno; Walz Jochen; Saad Fred; Hutterer Georg C; Bhojani Naeem; Shariat Shahrokh F; Perrotte Paul; Graefen Markus; Montorsi Francesco; Karakiewicz Pierre I
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
European urology 2008;54(1):107-16.
2008: Shariat Shahrokh F; Karam Jose A; Walz Jochen; Roehrborn Claus G; Montorsi Francesco; Margulis Vitaly; Saad Fred; Slawin Kevin M; Karakiewicz Pierre I
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3785-91.
2008: Shariat Shahrokh F; Trinh Quoc-Dien; Morey Allen F; Stage Key H; Roehrborn Claus G; Valiquette Luc; Karakiewicz Pierre I
Development of a highly accurate nomogram for prediction of the need for exploration in patients with renal trauma.
The Journal of trauma 2008;64(6):1451-8.
2008: Svatek Robert S; Karam Jose A; Roehrborn Claus G; Karakiewicz Pierre I; Slawin Kevin M; Shariat Shahrokh F
Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3362-6.
2008: Walz Jochen; Shariat Shahrokh F; Suardi Nazareno; Perrotte Paul; Lotan Yair; Palapattu Ganesh S; Gupta Amit; Bastian Patrick J; Rogers Craig G; Vazina Amnon; Amiel Gilad E; Sagalowsky Arthur I; Schoenberg Mark; Lerner Seth P; Karakiewicz Pierre I
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
BJU international 2008;101(11):1356-61.
2008: Lotan Yair; Bensalah Karim; Ruddell Timothy; Shariat Shahrokh F; Sagalowsky Arthur I; Ashfaq Raheela
Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
The Journal of urology 2008;179(6):2164-9.
2008: Gallina Andrea; Chun Felix K-H; Suardi Nazareno; Eastham James A; Perrotte Paul; Graefen Markus; Hutterer Georg; Huland Hartwig; Klein Eric A; Reuther Alwyn; Montorsi Francesco; Briganti Alberto; Shariat Shahrokh F; Roehrborn Claus G; de la Taille Alexandre; Salomon Laurent; Karakiewicz Pierre I
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
BJU international 2008;101(12):1513-8.
2008: Lotan Yair; Shariat Shahrokh F;
Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection.
BJU international 2008;101(11):1362-7.
2008: Shariat Shahrokh F; Karakiewicz Pierre I; Margulis Vitaly; Kattan Michael W
Inventory of prostate cancer predictive tools.
Current opinion in urology 2008;18(3):279-96.
2008: Karakiewicz Pierre I; Bhojani Naeem; Neugut Alfred; Shariat Shahrokh F; Jeldres Claudio; Graefen Markus; Perrotte Paul; Peloquin Francois; Kattan Michael W
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
The journal of sexual medicine 2008;5(4):919-27.
2008: Walz Jochen; Montorsi Francesco; Jeldres Claudio; Suardi Nazareno; Shariat Shahrokh F; Perrotte Paul; Arjane Philippe; Graefen Markus; Pharand Daniel; Karakiewicz Pierre I
The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.
BJU international 2008;101(7):826-32.
2008: Shariat Shahrokh F; Walz Jochen; Roehrborn Claus G; Montorsi Francesco; Jeldres Claudio; Saad Fred; Karakiewicz Pierre I
Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.
The Journal of urology 2008;179(4):1593-7.
2008: Karakiewicz Pierre I; Suardi Nazareno; Shariat Shahrokh F
The search for better prognostic factors for men treated for localized prostate cancer continues.
European urology 2008;53(4):689-90.
2008: Shariat Shahrokh F; Walz Jochen; Roehrborn Claus G; Zlotta Alexandre R; Perrotte Paul; Suardi Nazareno; Saad Fred; Karakiewicz Pierre I
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1526-31.
2008: Karam Jose A; Svatek Robert S; Karakiewicz Pierre I; Gallina Andrea; Roehrborn Claus G; Slawin Kevin M; Shariat Shahrokh F
Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1418-22.
2008: Hutterer Georg C; Karakiewicz Pierre I; Zippe Craig; Lüdecke Gerson; Boman Hans; Sanchez-Carbayo Marta; Casella Roberto; Mian Christine; Friedrich Martin G; Eissa Sanaa; Akaza Hideyuki; Serretta Vincenzo; Hedelin Hans; Rupesh Raina; Miyanaga Naoto; Sagalowsky Arthur I; Perrotte Paul; Lotan Yair; Marberger Michael J; Shariat Shahrokh F
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
BJU international 2008;101(5):561-5.
2008: Bhojani Naeem; Perrotte Paul; Jeldres Claudio; Suardi Nazareno; Hutterer Georg; Shariat Shahrokh F; Karakiewicz Pierre I
The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening.
The journal of sexual medicine 2008;5(3):668-76.
2008: Shariat Shahrokh F; Karakiewicz Pierre I
Screening for prostate cancer in 2007: the PSA era and its challenges are not over.
European urology 2008;53(3):457-60.
2008: Shariat Shahrokh F; Karam Jose A; Margulis Vitaly; Karakiewicz Pierre I
New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer.
BJU international 2008;101(6):675-83.
2008: Gupta Amit; Lotan Yair; Bastian Patrick J; Palapattu Ganesh S; Karakiewicz Pierre I; Raj Ganesh V; Schoenberg Mark P; Lerner Seth P; Sagalowsky Arthur I; Shariat Shahrokh F;
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
Urology 2008;71(2):302-7.
2008: Svatek Robert S; Karam Jose; Karakiewicz Pierre I; Gallina Andrea; Casella Roberto; Roehrborn Claus G; Shariat Shahrokh F
Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma.
The Journal of urology 2008;179(2):478-84; discussion 484.
2008: Margulis Vitaly; Lotan Yair; Shariat Shahrokh F
Survivin: a promising biomarker for detection and prognosis of bladder cancer.
World journal of urology 2008;26(1):59-65.
2008: Bastian Patrick J; Hutterer Georg C; Shariat Shahrokh F; Rogers Craig G; Palapattu Ganesh S; Lotan Yair; Vazina Amnon; Amiel Gilad E; Gupta Amit; Sagalowsky Arthur I; Lerner Seth P; Schoenberg Mark P; Karakiewicz Pierre I;
Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
BJU international 2008;101(4):450-4.
2008: Shariat Shahrokh F; Lamb Dolores J; Roehrborn Claus G; Slawin Kevin M
Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis.
Archives of internal medicine 2008;168(2):235-6.
2008: Shariat Shahrokh F; Lamb Dolores J; Iyengar Radha G; Roehrborn Claus G; Slawin Kevin M
Herbal/hormonal dietary supplement possibly associated with prostate cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(2):607-11.
2008: Shariat Shahrokh F; Karam Jose A; Lerner Seth P
Molecular markers in bladder cancer.
Current opinion in urology 2008;18(1):1-8.
2008: Shariat Shahrokh F; Karakiewicz Pierre I; Ashfaq Raheela; Lerner Seth P; Palapattu Ganesh S; Cote Richard J; Sagalowsky Arthur I; Lotan Yair
Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.
Cancer 2008;112(2):315-25.
2008: Shariat Shahrokh F; Svatek Robert S; Kabbani Wareef; Walz Jochen; Lotan Yair; Karakiewicz Pierre I; Roehrborn Claus G
Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy.
BJU international 2008;101(2):232-7.
2008: Shariat Shahrokh F; Roehrborn Claus G
Using biopsy to detect prostate cancer.
Reviews in urology 2008;10(4):262-80.
2008: Shariat Shahrokh F; Karam Jose A; Lotan Yair; Karakiewizc Pierre I
Critical evaluation of urinary markers for bladder cancer detection and monitoring.
Reviews in urology 2008;10(2):120-35.
2008: Bensalah K; Lotan Y; Karam J A; Shariat S F
New circulating biomarkers for prostate cancer.
Prostate cancer and prostatic diseases 2008;11(2):112-20.
2007: Briganti Alberto; Chun Felix K-H; Suardi Nazareno; Gallina Andrea; Walz Jochen; Graefen Markus; Shariat Shahrokh; Ebersdobler Andreas; Rigatti Patrizio; Perrotte Paul; Saad Fred; Montorsi Francesco; Huland Hartwig; Karakiewicz Pierre I
Prostate volume and adverse prostate cancer features: fact not artifact.
European journal of cancer (Oxford, England : 1990) 2007;43(18):2669-77.
2007: Walz Jochen; Gallina Andrea; Perrotte Paul; Jeldres Claudio; Trinh Quoc-Dien; Hutterer Georg C; Traumann Miriam; Ramirez Alvaro; Shariat Shahrokh F; McCormack Michael; Perreault Jean-Paul; Bénard Francois; Valiquette Luc; Saad Fred; Karakiewicz Pierre I
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
BJU international 2007;100(6):1254-8.
2007: Bensalah Karim; Montorsi Francesco; Shariat Shahrokh F
Challenges of cancer biomarker profiling.
European urology 2007;52(6):1601-9.
2007: Bensalah Karim; Traxer Olivier; Shariat Shahrokh F; Zimmern Philippe
[What are the differences between American and French urologists?]
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2007;17(7):1367-71.
2007: Shariat Shahrokh F; Ashfaq Raheela; Sagalowsky Arthur I; Lotan Yair
Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
Urologic oncology 2007;25(6):468-75.
2007: Nielsen Matthew E; Palapattu Ganesh S; Karakiewicz Pierre I; Lotan Yair; Bastian Patrick J; Lerner Seth P; Sagalowsky Arthur I; Schoenberg Mark P; Shariat Shahrokh F
A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.
BJU international 2007;100(5):1015-20.
2007: Huang Hong-Ying; Shariat Shahrokh F; Sun Tung-Tien; Lepor Herbert; Shapiro Ellen; Hsieh Jer-Tsong; Ashfaq Raheela; Lotan Yair; Wu Xue-Ru
Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome.
Human pathology 2007;38(11):1703-13.
2007: Gallina Andrea; Jeldres Claudio; Chun Felix K-H; Shariat Shahrokh F; Briganti Alberto; Walz Jochen; Roehrborn Claus G; Saad Fred; Huland Hartwig; Graefen Markus; Montorsi Francesco; Karakiewicz Pierre I
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
European urology 2007;52(5):1374-80.
2007: Shariat Shahrokh F; Park Sangtae; Trinh Quoc-Dien; Roehrborn Claus G; Slawin Kevin M; Karakiewicz Pierre I
Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.
The Journal of urology 2007;178(4 Pt 1):1229-36; discussion 1236-7.
2007: Chun Felix K-H; Briganti Alberto; Gallina Andrea; Hutterer Georg C; Shariat Shahrokh F; Antebie Elie; Walz Jochen; Roehrborn Claus G; Salonia Andrea; Rigatti Patrizio; Saad Fred; Huland Hartwig; Montorsi Francesco; Graefen Markus; Karakiewicz Pierre I
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
European urology 2007;52(4):1067-74.
2007: Karam Jose A; Lotan Yair; Ashfaq Raheela; Sagalowsky Arthur I; Shariat Shahrokh F
Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Urology 2007;70(3):482-6.
2007: Shariat Shahrokh F; Bensalah Karim; Karam Jose A; Roehrborn Claus G; Gallina Andrea; Lotan Yair; Slawin Kevin M; Karakiewicz Pierre I
Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5377-84.
2007: Briganti Alberto; Shariat Shahrokh F; Chun Felix K-H; Hutterer Georg C; Roehrborn Claus G; Gallina Andrea; Rigatti Patrizio; Valiquette Luc; Montorsi Francesco; Karakiewicz Pierre I
Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin.
BJU international 2007;100(3):528-32.
2007: Walz Jochen; Gallina Andrea; Hutterer Georg; Perrotte Paul; Shariat Shahrokh F; Graefen Markus; McCormack Michael; Bénard Francois; Valiquette Luc; Saad Fred; Karakiewicz Pierre I
Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.
International journal of radiation oncology, biology, physics 2007;69(1):88-94.
2007: Briganti Alberto; Chun Felix K-H; Hutterer Georg C; Gallina Andrea; Shariat Shahrokh F; Salonia Andrea; Scattoni Vincenzo; Valiquette Luc; Montorsi Francesco; Rigatti Patrizio; Graefen Markus; Huland Hartwig; Karakiewicz Pierre I
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
European urology 2007;52(3):733-43.
2007: Walz Jochen; Gallina Andrea; Saad Fred; Montorsi Francesco; Perrotte Paul; Shariat Shahrokh F; Jeldres Claudio; Graefen Markus; Bénard Francois; McCormack Michael; Valiquette Luc; Karakiewicz Pierre I
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3576-81.
2007: Karam Jose A; Shariat Shahrokh F; Huang Hong-Ying; Pong Rey-Chen; Ashfaq Raheela; Shapiro Ellen; Lotan Yair; Sagalowsky Arthur I; Wu Xue-Ru; Hsieh Jer-Tsong
Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4400-6.
2007: Shariat Shahrokh F; Karam Jose A; Roehrborn Claus G
Blood biomarkers for prostate cancer detection and prognosis.
Future oncology (London, England) 2007;3(4):449-61.
2007: Gallina Andrea; Karakiewicz Pierre I; Hutterer Georg C; Chun Felix K-H; Briganti Alberto; Walz Jochen; Antebi Elie; Shariat Shahrokh F; Suardi Nazareno; Graefen Markus; Erbersdobler Andreas; Salonia Andrea; Rigatti Patrizio; Huland Hartwig; Montorsi Francesco
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
International journal of cancer. Journal international du cancer 2007;121(4):791-5.
2007: Malaeb Bahaa S; Rashid Hani H; Lotan Yair; Khoddami Seyyed M; Shariat Shahrokh F; Sagalowsky Arthur I; McConnell John D; Roehrborn Claus G; Koeneman Kenneth S
Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
Urologic oncology 2007;25(4):291-7.
2007: Gallina Andrea; Chun Felix K-H; Briganti Alberto; Shariat Shahrokh F; Montorsi Francesco; Salonia Andrea; Erbersdobler Andreas; Rigatti Patrizio; Valiquette Luc; Huland Hartwig; Graefen Markus; Karakiewicz Pierre I
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
European urology 2007;52(1):98-105.
2007: Karam Jose A; Lotan Yair; Roehrborn Claus G; Ashfaq Raheela; Karakiewicz Pierre I; Shariat Shahrokh F
Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence.
The Prostate 2007;67(6):614-22.
2007: Shariat Shahrokh F; Roehrborn Claus G; Karakiewicz Pierre I; Dhami Gurleen; Stage Key H
Evidence-based validation of the predictive value of the American Association for the Surgery of Trauma kidney injury scale.
The Journal of trauma 2007;62(4):933-9.
2007: Shariat Shahrokh F; Zlotta Alexandre R; Ashfaq Raheela; Sagalowsky Arthur I; Lotan Yair
Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(4):445-59.
2007: Shariat Shahrokh F; Ashfaq Raheela; Karakiewicz Pierre I; Saeedi Osamah; Sagalowsky Arthur I; Lotan Yair
Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.
Cancer 2007;109(6):1106-13.
2007: Margulis Vitaly; Shariat Shahrokh F; Ashfaq Raheela; Thompson Melissa; Sagalowsky Arthur I; Hsieh Jer-Tsong; Lotan Yair
Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.
The Journal of urology 2007;177(3):1163-8.
2007: Nielsen Matthew E; Shariat Shahrokh F; Karakiewicz Pierre I; Lotan Yair; Rogers Craig G; Amiel Gilad E; Bastian Patrick J; Vazina Amnon; Gupta Amit; Lerner Seth P; Sagalowsky Arthur I; Schoenberg Mark P; Palapattu Ganesh S;
Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy.
European urology 2007;51(3):699-706; discussion 706-8.
2007: Karam Jose A; Lotan Yair; Karakiewicz Pierre I; Ashfaq Raheela; Sagalowsky Arthur I; Roehrborn Claus G; Shariat Shahrokh F
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.
The lancet oncology 2007;8(2):128-36.
2007: Shariat Shahrokh F; Roehrborn Claus G; McConnell John D; Park Sangtae; Alam Nina; Wheeler Thomas M; Slawin Kevin M
Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(4):349-55.
2007: Shariat Shahrokh F; Ashfaq Raheela; Sagalowsky Arthur I; Lotan Yair
Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
The Journal of urology 2007;177(2):481-7; discussion 487.
2007: Shariat Shahrokh F; Palapattu Ganesh S; Karakiewicz Pierre I; Rogers Craig G; Vazina Amnon; Bastian Patrick J; Schoenberg Mark P; Lerner Seth P; Sagalowsky Arthur I; Lotan Yair
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
European urology 2007;51(1):152-60.
2007: Shariat Shahrokh F; Palapattu Ganesh S; Karakiewicz Pierre I; Rogers Craig G; Vazina Amnon; Bastian Patrick J; Schoenberg Mark P; Lerner Seth P; Sagalowsky Arthur I; Lotan Yair
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.
European urology 2007;51(1):137-49; discussion 149-51.
2007: Shariat Shahrokh F
Selecting patients for immediate cystectomy.
Reviews in urology 2007;9(4):239-41.
2006: Margulis Vitaly; Shariat Shahrokh F; Ashfaq Raheela; Sagalowsky Arthur I; Lotan Yair
Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7369-73.
2006: Shariat Shahrokh F; Karakiewicz Pierre I; Palapattu Ganesh S; Lotan Yair; Rogers Craig G; Amiel Gilad E; Vazina Amnon; Gupta Amit; Bastian Patrick J; Sagalowsky Arthur I; Schoenberg Mark P; Lerner Seth P
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
The Journal of urology 2006;176(6 Pt 1):2414-22; discussion 2422.
2006: Shariat Shahrokh F; Ashfaq Raheela; Sagalowsky Arthur I; Lotan Yair
Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis.
Human pathology 2006;37(12):1568-76.
2006: Karakiewicz Pierre I; Shariat Shahrokh F; Palapattu Ganesh S; Perrotte Paul; Lotan Yair; Rogers Craig G; Amiel Gilad E; Vazina Amnon; Gupta Amit; Bastian Patrick J; Sagalowsky Arthur I; Schoenberg Mark; Lerner Seth P
Precystectomy nomogram for prediction of advanced bladder cancer stage.
European urology 2006;50(6):1254-60; discussion 1261-2.
2006: Shariat Shahrokh F; Karakiewicz Pierre I; Palapattu Ganesh S; Amiel Gilad E; Lotan Yair; Rogers Craig G; Vazina Amnon; Bastian Patrick J; Gupta Amit; Sagalowsky Arthur I; Schoenberg Mark; Lerner Seth P
Nomograms provide improved accuracy for predicting survival after radical cystectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6663-76.
2006: Karakiewicz Pierre I; Shariat Shahrokh F; Palapattu Ganesh S; Gilad Amiel E; Lotan Yair; Rogers Craig G; Vazina Amnon; Gupta Amit; Bastian Patrick J; Perrotte Paul; Sagalowsky Arthur I; Schoenberg Mark; Lerner Seth P
Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
The Journal of urology 2006;176(4 Pt 1):1354-61; discussion 1361-2.
2006: Shariat Shahrokh F; Palapattu Ganesh S; Amiel Gilad E; Karakiewicz Pierre I; Rogers Craig G; Vazina Amnon; Schoenberg Mark P; Lerner Seth P; Sagalowsky Arthur I; Lotan Yair
Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy.
Urology 2006;68(3):538-42.
2006: Shariat Shahrokh F; Marberger Michael J; Lotan Yair; Sanchez-Carbayo Marta; Zippe Craig; Lüdecke Gerson; Boman Hans; Sawczuk Ihor; Friedrich Martin G; Casella Roberto; Mian Christine; Eissa Sanaa; Akaza Hideyuki; Serretta Vincenzo; Huland Hartwig; Hedelin Hans; Raina Rupesh; Miyanaga Naoto; Sagalowsky Arthur I; Roehrborn Claus G; Karakiewicz Pierre I
Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.
The Journal of urology 2006;176(3):919-26; discussion 926.
2006: Chun Felix K-H; Briganti Alberto; Shariat Shahrokh F; Graefen Markus; Montorsi Francesco; Erbersdobler Andreas; Steuber Thomas; Salonia Andrea; Currlin Eike; Scattoni Vincenzo; Friedrich Martin G; Schlomm Thorsten; Haese Alexander; Michl Uwe; Colombo Renzo; Heinzer Hans; Valiquette Luc; Rigatti Patrizio; Roehrborn Claus G; Huland Hartwig; Karakiewicz Pierre I
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
BJU international 2006;98(2):329-34.
2006: Walsh Lance P; Zimmern Philippe E; Pope Norma; Shariat Shahrokh F;
Comparison of the Q-tip test and voiding cystourethrogram to assess urethral hypermobility among women enrolled in a randomized clinical trial of surgery for stress urinary incontinence.
The Journal of urology 2006;176(2):646-9; discussion 650.
2006: Rogers Craig G; Palapattu Ganesh S; Shariat Shahrokh F; Karakiewicz Pierre I; Bastian Patrick J; Lotan Yair; Gupta Amit; Vazina Amnon; Gilad Amiel; Sagalowsky Arthur I; Lerner Seth P; Schoenberg Mark P
Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
The Journal of urology 2006;175(6):2048-53; discussion 2053.
2006: Palapattu Ganesh S; Shariat Shahrokh F; Karakiewicz Pierre I; Bastian Patrick J; Rogers Craig G; Amiel Gilad; Lotan Yair; Vazina Amnon; Gupta Amit; Sagalowsky Arthur I; Lerner Seth P; Schoenberg Mark P;
Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
The Journal of urology 2006;175(5):1645-9; discussion 1649.
2006: Karakiewicz Pierre I; Benayoun Serge; Zippe Craig; Lüdecke Gerson; Boman Hans; Sanchez-Carbayo Marta; Casella Roberto; Mian Christine; Friedrich Martin G; Eissa Sanaa; Akaza Hideyuki; Huland Hartwig; Hedelin Hans; Rupesh Raina; Miyanaga Naoto; Sagalowsky Arthur I; Marberger Michael J; Shariat Shahrokh F
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder.
BJU international 2006;97(5):997-1001.
2006: Svatek Robert S; Herman Michael P; Lotan Yair; Casella Roberto; Hsieh Jer-Tsong; Sagalowsky Arthur I; Shariat Shahrokh F
Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.
Cancer 2006;106(8):1701-7.
2006: Shariat Shahrokh F; Abdel-Aziz Khaled F; Roehrborn Claus G; Lotan Yair
Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
European urology 2006;49(2):293-302.
2005: Shariat Shahrokh F; Duchene David; Kabbani Wareef; Mucher Zachary; Lotan Yair
Gastrointestinal hemorrhage as first manifestation of metastatic testicular tumor.
Urology 2005;66(6):1319.
2005: Shariat Shahrokh F; Ashfaq Raheela; Roehrborn Claus G; Slawin Kevin M; Lotan Yair
Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
The Journal of urology 2005;174(5):2046-50.
2005: Shariat Shahrokh F; Raptidis Grigorios; Masatoschi Muramoto; Bergamaschi Franco; Slawin Kevin M
Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer.
The Prostate 2005;65(3):260-7.
2005: Lotan Yair; Gupta Amit; Shariat Shahrokh F; Palapattu Ganesh S; Vazina Amnon; Karakiewicz Pierre I; Bastian Patrick J; Rogers Craig G; Amiel Gilad; Perotte Paul; Schoenberg Mark P; Lerner Seth P; Sagalowsky Arthur I
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6533-9.
2005: Shariat Shahrokh F; Herman Michael P; Casella Roberto; Lotan Yair; Karam Jose A; Stenman Ulf-Håkan
Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.
European urology 2005;48(3):424-31.
2005: Matsumoto Kazumasa; Shariat Shahrokh F; Ayala Gustavo E; Rauen Katherine A; Lerner Seth P
Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer.
Urology 2005;66(2):441-6.
2005: Shariat Shahrokh F; Matsumoto Kazumasa; Casella Roberto; Jian Weiguo; Lerner Seth P
Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder.
European urology 2005;48(1):69-76.
2005: Shariat Shahrokh F; Zippe Craig; Lüdecke Gerson; Boman Hans; Sanchez-Carbayo Marta; Casella Roberto; Mian Christine; Friedrich Martin G; Eissa Sanaa; Akaza Hideyuki; Sawczuk Ihor; Serretta Vincenzo; Huland Hartwig; Hedelin Hans; Rupesh Raina; Miyanaga Naoto; Sagalowsky Arthur I; Wians Frank; Roehrborn Claus G; Lotan Yair; Perrotte Paul; Benayoun Serge; Marberger Michael J; Karakiewicz Pierre I
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
The Journal of urology 2005;173(5):1518-25.
2005: Ramirez Alvaro; Perrotte Paul; Valiquette Luc; Benard Francois; McCormack Mike; Saad Fred; Fournier Caroline; Shariat Shahrokh; Karakiewicz Pierre I
Exploration of health-related quality of life areas that may distinguish between continent diversion and ileal conduit patients.
The Canadian journal of urology 2005;12(1):2537-42.
2005: Karakiewicz Pierre; Shariat Shahrokh F; Naderi Amir; Kadmon Dov; Slawin Kevin M
Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer.
Urology 2005;65(1):131-5.
2005: Slawin Kevin M; Shariat Shahrokh; Canto Eduardo
BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia.
Reviews in urology 2005;7 Suppl 8():S52-6.
2005: Shariat Shahrokh F; Naderi Amir Said Alizadeh; Miles Brian; Slawin Kevin M
Anomalies of the wolffian duct derivatives encountered at radical prostatectomy.
Reviews in urology 2005;7(2):75-80.
2004: Canto Eduardo I; Singh Herb; Shariat Shahrokh F; Kadmon Dov; Miles Brian J; Wheeler Thomas M; Slawin Kevin M
Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection.
The Journal of urology 2004;172(3):900-4.
2004: Khoddami Seyed M; Shariat Shahrokh F; Lotan Yair; Saboorian Hossein; McConnell John D; Sagalowsky Arthur I; Roehrborn Claus G; Koeneman Kenneth S
Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.
BJU international 2004;94(1):42-6.
2004: Shariat Shahrokh F; Menesses-Diaz Andres; Kim Isaac Y; Muramoto Masatoschi; Wheeler Thomas M; Slawin Kevin M
Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
Urology 2004;63(6):1191-7.
2004: Singh Herb; Karakiewicz Pierre; Shariat Shahrokh F; Canto Eduardo I; Nath Rahul K; Kattan Michael W; Slawin Kevin M
Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy.
Urology 2004;63(6):1122-7.
2004: Canto Eduardo I; Shariat Shahrokh F; Slawin Kevin M
Molecular diagnosis of prostate cancer.
Current urology reports 2004;5(3):203-11.
2004: Link Richard E; Shariat Shahrokh F; Nguyen Cuong V; Farr Anita; Weinberg Armin D; Morton Ronald A; Richardson Barbara; Bernard David; Slawin Kevin M
Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening.
The Journal of urology 2004;171(6 Pt 1):2234-8.
2004: Lotan Yair; Shariat Shahrokh F; Khoddami Seyed M; Saboorian Hossein; Koeneman Kenneth S; Cadeddu Jeffrey A; Sagalowsky Arthur I; McConnell John D; Roehrborn Claus G
The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.
The Journal of urology 2004;171(6 Pt 1):2209-14.
2004: Canto Eduardo I; Singh Herb; Shariat Shahrokh F; Lamb Dolores J; Mikolajczyk Stephen D; Linton Harry J; Rittenhouse Harry G; Kadmon Dov; Miles Brian J; Slawin Kevin M
Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer.
Urology 2004;63(5):905-10; discussion 910-1.
2004: Shariat Shahrokh F; Anwuri Veronica A; Lamb Dolores J; Shah Nina V; Wheeler Thomas M; Slawin Kevin M
Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1655-63.
2004: Singh Herb; Canto Eduardo I; Shariat Shahrokh F; Kadmon Dov; Miles Brian J; Wheeler Thomas M; Slawin Kevin M
Predictors of prostate cancer after initial negative systematic 12 core biopsy.
The Journal of urology 2004;171(5):1850-4.
2004: Ohori Makoto; Kattan Michael W; Koh Hideshige; Maru Norio; Slawin Kevin M; Shariat Shahrokh; Muramoto Masatoshi; Reuter Victor E; Wheeler Thomas M; Scardino Peter T
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.
The Journal of urology 2004;171(5):1844-9; discussion 1849.
2004: Vazina Amnon; Dugi Daniel; Shariat Shahrokh F; Evans Jeff; Link Richard; Lerner Seth P
Stage specific lymph node metastasis mapping in radical cystectomy specimens.
The Journal of urology 2004;171(5):1830-4.
2004: Shariat Shahrokh F; Kattan Michael W; Traxel Erica; Andrews Ben; Zhu Kuichun; Wheeler Thomas M; Slawin Kevin M
Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1992-9.
2004: Shariat Shahrokh F; Casella Roberto; Wians Frank H; Ashfaq Raheela; Balko Jody; Sulser Tullio; Gasser Thomas C; Sagalowsky Arthur I
Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology.
European urology 2004;45(3):304-13; author reply 313.
2004: Stephenson Andrew J; Shariat Shahrokh F; Zelefsky Michael J; Kattan Michael W; Butler E Brian; Teh Bin S; Klein Eric A; Kupelian Patrick A; Roehrborn Claus G; Pistenmaa David A; Pacholke Heather D; Liauw Stanley L; Katz Matthew S; Leibel Steven A; Scardino Peter T; Slawin Kevin M
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
JAMA : the journal of the American Medical Association 2004;291(11):1325-32.
2004: Shariat Shahrokh F; Tokunaga Hideo; Zhou JainHua; Kim JaHong; Ayala Gustavo E; Benedict William F; Lerner Seth P
p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1014-24.
2004: Shariat Shahrokh F; Khoddami Seyed M; Saboorian Hossein; Koeneman Kenneth S; Sagalowsky Arthur I; Cadeddu Jeffrey A; McConnell John D; Holmes Marisa N; Roehrborn Claus G
Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy.
The Journal of urology 2004;171(3):1122-7.
2004: Singh Herb; Canto Eduardo I; Shariat Shahrokh F; Kadmon Dov; Miles Brian J; Wheeler Thomas M; Slawin Kevin M
Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.
The Journal of urology 2004;171(3):1089-92.
2004: Shariat Shahrokh F; Lotan Yair; Saboorian Hossein; Khoddami Seyed M; Roehrborn Claus G; Slawin Kevin M; Ashfaq Raheela
Survivin expression is associated with features of biologically aggressive prostate carcinoma.
Cancer 2004;100(4):751-7.
2004: Shariat Shahrokh F; Casella Roberto; Khoddami Seyed M; Hernandez Gina; Sulser Tullio; Gasser Thomas C; Lerner Seth P
Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer.
The Journal of urology 2004;171(2 Pt 1):626-30.
2004: Singh Herb; Canto Eduardo I; Shariat Shahrokh F; Kadmon Dov; Miles Brian J; Wheeler Thomas M; Slawin Kevin M
Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.
The Journal of urology 2004;171(1):204-9.
2004: Shariat Shahrokh F; Canto Eduardo I; Kattan Michael W; Slawin Kevin M
Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer.
Reviews in urology 2004;6(2):58-72.
2003: Matsumoto Kazumasa; Shariat Shahrokh F; Casella Roberto; Wheeler Thomas M; Slawin Kevin M; Lerner Seth P
Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy.
The Journal of urology 2003;170(6 Pt 1):2248-52.
2003: Shariat Shahrokh F; Casella Roberto; Monoski Mara A; Sulser Tullio; Gasser Thomas C; Lerner Seth P
The addition of urinary urokinase-type plasminogen activator to urinary nuclear matrix protein 22 and cytology improves the detection of bladder cancer.
The Journal of urology 2003;170(6 Pt 1):2244-7.
2003: Kattan Michael W; Eastham James A; Wheeler Thomas M; Maru Norio; Scardino Peter T; Erbersdobler Andreas; Graefen Markus; Huland Hartwig; Koh Hideshige; Shariat Shahrokh F; Slawin Kevin M; Ohori Makoto
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.
The Journal of urology 2003;170(5):1792-7.
2003: Kattan Michael W; Shariat Shahrokh F; Andrews Ben; Zhu Kuichun; Canto Eduardo; Matsumoto Kazumasa; Muramoto Masatoshi; Scardino Peter T; Ohori Makoto; Wheeler Thomas M; Slawin Kevin M
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3573-9.
2003: Shariat Shahrokh F; Kattan Michael W; Song Weitao; Bernard David; Gottenger Emanuel; Wheeler Thomas M; Slawin Kevin M
Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
Cancer research 2003;63(18):5874-8.
2003: Shariat Shanrokh F; Matsumoto Kazumasa; Kim JaHong; Ayala Gustavo E; Zhou Jain-Hua; Jian Weiguo; Benedict William F; Lerner Seth P
Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.
The Journal of urology 2003;170(3):985-9.
2003: Shariat Shahrokh F; Roudier Martine P; Wilcox George E; Kattan Michael W; Scardino Peter T; Vessella Robert L; Erdamar Sibel; Nguyen Cuong; Wheeler Thomas M; Slawin Kevin M
Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Cancer research 2003;63(15):4662-70.
2003: Shariat Shahrokh F; Kim JaHong; Raptidis Grigorios; Ayala Gustavo E; Lerner Seth P
Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder.
Urology 2003;61(6):1140-5.
2003: Shariat Shahrokh F; Monoski Mara A; Andrews Ben; Wheeler Thomas M; Lerner Seth P; Slawin Kevin M
Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.
Urology 2003;61(5):1053-8.
2003: Canto Eduardo I; Shariat Shahrokh F; Slawin Kevin M
Biochemical staging of prostate cancer.
The Urologic clinics of North America 2003;30(2):263-77.
2003: Shariat Shahrokh F; Kattan Michael W; Erdamar Sibel; Nguyen Cuong; Scardino Peter T; Spencer David M; Wheeler Thomas M; Slawin Kevin M
Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1223-31.
2003: Shariat Shahrokh F; Kim Ja-Hong; Ayala Gustavo E; Kho Kimberly; Wheeler Thomas M; Lerner Seth P
Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.
The Journal of urology 2003;169(3):938-42.
2003: Shariat Shahrokh F; Kim JaHong; Nguyen Cuong; Wheeler Thomas M; Lerner Seth P; Slawin Kevin M
Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer.
Urology 2003;61(2):359-64.
2003: Shariat Shahrokh F; Slawin Kevin M
Peripheral blood rt-PCR assays for detection and prognosis of prostate cancer.
Reviews in urology 2003;5(1):54-8.
2002: Casella Roberto; Shariat Shahrokh F; Monoski Mara A; Lerner Seth P
Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.
Cancer 2002;95(12):2494-9.
2002: Shariat Shahrokh F; Gottenger Emanuel; Nguyen Cuong; Song Weitao; Kattan Michael W; Andenoro John; Wheeler Thomas M; Spencer David M; Slawin Kevin M
Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
Cancer research 2002;62(20):5974-9.
2002: Andrews Ben; Shariat Shahrokh F; Kim Ja-Hong; Wheeler Thomas M; Slawin Kevin M; Lerner Seth P
Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.
The Journal of urology 2002;167(3):1475-81.
2002: Shariat Shahrokh F; Lamb Dolores J; Kattan Michael W; Nguyen Cuong; Kim JaHong; Beck Josie; Wheeler Thomas M; Slawin Kevin M
Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):833-41.
2002: Weizer Alon Z; Shariat Shahrokh F; Haddad John L; Escudier Susan; Lerner Seth P
Metastatic transitional cell carcinoma of the urinary bladder to the shoulder girdle.
Reviews in urology 2002;4(2):97-9.
2002: Slawin Kevin M; Canto Eduardo I; Shariat Shahrokh F; Gore John L; Kim Edward; Kattan Michael W; Wheeler Thomas M; Nath Rahul K
Sural Nerve Interposition Grafting during Radical Prostatectomy.
Reviews in urology 2002;4(1):17-23.
2001: Shariat S F; Kim J H; Andrews B; Kattan M W; Wheeler T M; Kim I Y; Lerner S P; Slawin K M
Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma.
Cancer 2001;92(12):2985-92.
2001: Shariat S F; Andrews B; Kattan M W; Kim J; Wheeler T M; Slawin K M
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.
Urology 2001;58(6):1008-15.
2001: Kim J H; Shariat S F; Kim I Y; Menesses-Diaz A; Tokunaga H; Wheeler T M; Lerner S P
Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder.
Cancer 2001;92(6):1475-83.
2001: Tokunaga H; Shariat S F; Green A E; Brown R M; Zhou J H; Benedict W F; Lerner S P
Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens.
International journal of radiation oncology, biology, physics 2001;51(1):16-22.
2001: Shariat S F; Shalev M; Menesses-Diaz A; Kim I Y; Kattan M W; Wheeler T M; Slawin K M
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2856-64.
2001: Gore J L; Shariat S F; Miles B J; Kadmon D; Jiang N; Wheeler T M; Slawin K M
Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer.
The Journal of urology 2001;165(5):1554-9.
2001: Byrne R R; Shariat S F; Brown R; Kattan M W; Morton RA J R; Wheeler T M; Lerner S P
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
The Journal of urology 2001;165(5):1473-9.
2001: Leventis A K; Shariat S F; Slawin K M
Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings.
Radiology 2001;219(2):432-9.
2001: Shariat S F; Desai S; Song W; Khan T; Zhao J; Nguyen C; Foster B A; Greenberg N; Spencer D M; Slawin K M
Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer.
Cancer research 2001;61(6):2562-71.
2001: Leventis A K; Shariat S F; Utsunomiya T; Slawin K M
Characteristics of normal prostate vascular anatomy as displayed by power Doppler.
The Prostate 2001;46(4):281-8.
2001: Leventis A K; Shariat S F; Kattan M W; Butler E B; Wheeler T M; Slawin K M
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1030-9.
2001: Shariat S F; Pahlavan S; Baseman A G; Brown R M; Green A E; Wheeler T M; Lerner S P
E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder.
Urology 2001;57(1):60-5.
2000: Slawin K M; Shariat S F; Nguyen C; Leventis A K; Song W; Kattan M W; Young C Y; Tindall D J; Wheeler T M
Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.
Cancer research 2000;60(24):7142-8.
2000: Shariat S F; Weizer A Z; Green A; Laucirica R; Frolov A; Wheeler T M; Lerner S P
Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.
Urology 2000;56(5):735-40.
2000: Shariat S F; Bergamaschi F; Adler H L; Nguyen C; Kattan M W; Wheeler T M; Slawin K M
Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy.
Urology 2000;56(3):423-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Shahrokh Shariat

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Shahrokh Shariat (preview)

All Publications